Product Catalog [{"id":"463","name":"Evaluation of Parsaclisib plus Bendamustine and Rituximab in patients with Newly Diagnosed Mantle Cell Lymphoma","price":1,"sku":"lymphoma-trial-2","brand":false,"position":1,"category":"Medicines\/| Clinical Trials"},{"id":"462","name":"Evaluation of Tafasitamab plus Rituximab and Lenalidomide in patients with Lymphoma that has stopped responding to treatment","price":1,"sku":"lymphoma-trial-3","brand":false,"position":2,"category":"Medicines\/| Clinical Trials"},{"id":"461","name":"Evaluation of Parsaclisib plus Rituximab or Obinutuzumab in patients with Lymphoma that has stopped responding to treatment","price":1,"sku":"lymphoma-trial-4","brand":false,"position":3,"category":"Medicines\/| Clinical Trials"},{"id":"460","name":"Evaluation of Tafasitamab plus Parsaclisib in patients with Non Hodgkin Lymphoma or Chronic Lymphocytic Leukemia","price":1,"sku":"lymphoma-leukemia-trial-1","brand":false,"position":4,"category":"Medicines\/| Clinical Trials"},{"id":"459","name":"Evaluation of Parsaclisib plus Ruxolitinib in patients with Myelofibrosis who have not responded to Ruxolitinib alone","price":1,"sku":"myelofibrosis-trial-1","brand":false,"position":5,"category":"Medicines\/| Clinical Trials"},{"id":"458","name":"Evaluation of Nivolumab plus Docetaxel in men with Prostate Cancer","price":1,"sku":"prostate-cancer-trial-1","brand":false,"position":6,"category":"Medicines\/| Clinical Trials"}]

Medicine access options

  1. Zejula
    Zejula (niraparib)
    Gynaecological Cancer
    €5,986.42
  2. Xeljanz
    Xeljanz (tofacitinib)
    Rheumatoid Arthritis
    €1,198.35
  3. Xadago
    Xadago (safinamide)
    Parkinson's Disease
    €201.22
  4. Tymlos
    Tymlos (abaloparatide)
    Osteoporosis
    €3,220.00
  5. Tecentriq
    Tecentriq (Atezolizumab)
    Urothelial Carcinoma, Breast Cancer, Lung Cancer
    €7,452.90
  6. Taltz
    Taltz (ixekizumab)
    Psoriasis
    €3,185.16
  7. Tagrisso
    Tagrisso (osimertinib)
    Lung Cancer
    €6,838.00
  8. Spinraza
    Spinraza (Nusinersen)
    Spinal Muscular Atrophy
    Price available on request
  9. Rydapt
    Rydapt (midostaurin)
    Leukemia
    €18,846.76
  10. Rubraca
    Rubraca (rucaparib)
    Gynaecological Cancer
    €2,021.44
  11. Portrazza
    Portrazza (necitumumab)
    Lung Cancer
    €9,241.93
View as Grid List

Items 1-12 of 348

Set Descending Direction
US 0